Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis

Dimethyl sulfoxide (DMSO) had not been regarded as a therapeutic drug against amyloidosis until 1974 when Osserman and Isobe administered it for the first time in six cases of primary amyloidosis. In 1973, we described an outline of the second largest concentration of familial amyloid polyneuropathy...

Full description

Saved in:
Bibliographic Details
Main Authors: Kito,Shozo, Itoga,Eiko, Inokawa,Masae, Hironaka,Masatoshi, Kishida,Takenobu
Format: Report
Language:English
Subjects:
Amyloidosis
Chemotherapy
Component reports
Dimethyl sulfoxide
In vitro analysis
Methyl sulfoxide
Patients
Symposia
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Kito,Shozo
Itoga,Eiko
Inokawa,Masae
Hironaka,Masatoshi
Kishida,Takenobu
description Dimethyl sulfoxide (DMSO) had not been regarded as a therapeutic drug against amyloidosis until 1974 when Osserman and Isobe administered it for the first time in six cases of primary amyloidosis. In 1973, we described an outline of the second largest concentration of familial amyloid polyneuropathy (FAP) cases which we discovered. We reported some tentative results of DMSO treatment in 18 cases. In this paper, we are presenting the effects of DMSO administration to patients with primary and familial amyloidosis from both clinical and biochemical viewpoints and in vitro effects of DMSO on extracted amyloid fibril proteins. This article is from 'Conference on Biological Actions and Medical Applications of Dimethyl Sulfoxide (DMSO), 15-17 September 1982,' AD-A133 175. p52-66.
format report
fullrecord <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_ADP001831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADP001831</sourcerecordid><originalsourceid>FETCH-dtic_stinet_ADP0018313</originalsourceid><addsrcrecordid>eNrjZPAOLilNyUwtVsjPU3DKzM_JT89MTsxRcEwuyczPA4qmKbhk5qaWZFTmKASX5qTlV2SmpCpk5im4JeZm5mSCVOZW5uRnpuQXZxbzMLCmJeYUp_JCaW4GGTfXEGcP3ZSSzOT44pLMvNSSeEeXAAMDQwtjQ2MC0gAiSzJV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis</title><source>DTIC Technical Reports</source><creator>Kito,Shozo ; Itoga,Eiko ; Inokawa,Masae ; Hironaka,Masatoshi ; Kishida,Takenobu</creator><creatorcontrib>Kito,Shozo ; Itoga,Eiko ; Inokawa,Masae ; Hironaka,Masatoshi ; Kishida,Takenobu ; HIROSHIMA UNIV (JAPAN) SCHOOL OF MEDICINE</creatorcontrib><description>Dimethyl sulfoxide (DMSO) had not been regarded as a therapeutic drug against amyloidosis until 1974 when Osserman and Isobe administered it for the first time in six cases of primary amyloidosis. In 1973, we described an outline of the second largest concentration of familial amyloid polyneuropathy (FAP) cases which we discovered. We reported some tentative results of DMSO treatment in 18 cases. In this paper, we are presenting the effects of DMSO administration to patients with primary and familial amyloidosis from both clinical and biochemical viewpoints and in vitro effects of DMSO on extracted amyloid fibril proteins. This article is from 'Conference on Biological Actions and Medical Applications of Dimethyl Sulfoxide (DMSO), 15-17 September 1982,' AD-A133 175. p52-66.</description><language>eng</language><subject>Amyloidosis ; Chemotherapy ; Component reports ; Dimethyl sulfoxide ; In vitro analysis ; Methyl sulfoxide ; Patients ; Symposia</subject><creationdate>1983</creationdate><rights>APPROVED FOR PUBLIC RELEASE</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,780,885,27567,27568</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/ADP001831$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kito,Shozo</creatorcontrib><creatorcontrib>Itoga,Eiko</creatorcontrib><creatorcontrib>Inokawa,Masae</creatorcontrib><creatorcontrib>Hironaka,Masatoshi</creatorcontrib><creatorcontrib>Kishida,Takenobu</creatorcontrib><creatorcontrib>HIROSHIMA UNIV (JAPAN) SCHOOL OF MEDICINE</creatorcontrib><title>Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis</title><description>Dimethyl sulfoxide (DMSO) had not been regarded as a therapeutic drug against amyloidosis until 1974 when Osserman and Isobe administered it for the first time in six cases of primary amyloidosis. In 1973, we described an outline of the second largest concentration of familial amyloid polyneuropathy (FAP) cases which we discovered. We reported some tentative results of DMSO treatment in 18 cases. In this paper, we are presenting the effects of DMSO administration to patients with primary and familial amyloidosis from both clinical and biochemical viewpoints and in vitro effects of DMSO on extracted amyloid fibril proteins. This article is from 'Conference on Biological Actions and Medical Applications of Dimethyl Sulfoxide (DMSO), 15-17 September 1982,' AD-A133 175. p52-66.</description><subject>Amyloidosis</subject><subject>Chemotherapy</subject><subject>Component reports</subject><subject>Dimethyl sulfoxide</subject><subject>In vitro analysis</subject><subject>Methyl sulfoxide</subject><subject>Patients</subject><subject>Symposia</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>1983</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNrjZPAOLilNyUwtVsjPU3DKzM_JT89MTsxRcEwuyczPA4qmKbhk5qaWZFTmKASX5qTlV2SmpCpk5im4JeZm5mSCVOZW5uRnpuQXZxbzMLCmJeYUp_JCaW4GGTfXEGcP3ZSSzOT44pLMvNSSeEeXAAMDQwtjQ2MC0gAiSzJV</recordid><startdate>198306</startdate><enddate>198306</enddate><creator>Kito,Shozo</creator><creator>Itoga,Eiko</creator><creator>Inokawa,Masae</creator><creator>Hironaka,Masatoshi</creator><creator>Kishida,Takenobu</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>198306</creationdate><title>Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis</title><author>Kito,Shozo ; Itoga,Eiko ; Inokawa,Masae ; Hironaka,Masatoshi ; Kishida,Takenobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_ADP0018313</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Amyloidosis</topic><topic>Chemotherapy</topic><topic>Component reports</topic><topic>Dimethyl sulfoxide</topic><topic>In vitro analysis</topic><topic>Methyl sulfoxide</topic><topic>Patients</topic><topic>Symposia</topic><toplevel>online_resources</toplevel><creatorcontrib>Kito,Shozo</creatorcontrib><creatorcontrib>Itoga,Eiko</creatorcontrib><creatorcontrib>Inokawa,Masae</creatorcontrib><creatorcontrib>Hironaka,Masatoshi</creatorcontrib><creatorcontrib>Kishida,Takenobu</creatorcontrib><creatorcontrib>HIROSHIMA UNIV (JAPAN) SCHOOL OF MEDICINE</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kito,Shozo</au><au>Itoga,Eiko</au><au>Inokawa,Masae</au><au>Hironaka,Masatoshi</au><au>Kishida,Takenobu</au><aucorp>HIROSHIMA UNIV (JAPAN) SCHOOL OF MEDICINE</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis</btitle><date>1983-06</date><risdate>1983</risdate><abstract>Dimethyl sulfoxide (DMSO) had not been regarded as a therapeutic drug against amyloidosis until 1974 when Osserman and Isobe administered it for the first time in six cases of primary amyloidosis. In 1973, we described an outline of the second largest concentration of familial amyloid polyneuropathy (FAP) cases which we discovered. We reported some tentative results of DMSO treatment in 18 cases. In this paper, we are presenting the effects of DMSO administration to patients with primary and familial amyloidosis from both clinical and biochemical viewpoints and in vitro effects of DMSO on extracted amyloid fibril proteins. This article is from 'Conference on Biological Actions and Medical Applications of Dimethyl Sulfoxide (DMSO), 15-17 September 1982,' AD-A133 175. p52-66.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_dtic_stinet_ADP001831
source DTIC Technical Reports
subjects Amyloidosis
Chemotherapy
Component reports
Dimethyl sulfoxide
In vitro analysis
Methyl sulfoxide
Patients
Symposia
title Studies on Biological Actions of Dimethyl Sulfoxide in Familial Amyloidosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A14%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=Studies%20on%20Biological%20Actions%20of%20Dimethyl%20Sulfoxide%20in%20Familial%20Amyloidosis&rft.au=Kito,Shozo&rft.aucorp=HIROSHIMA%20UNIV%20(JAPAN)%20SCHOOL%20OF%20MEDICINE&rft.date=1983-06&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EADP001831%3C/dtic_1RU%3E%3Cgrp_id%3Ecdi_FETCH-dtic_stinet_ADP0018313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true